What does the evidence say about Lactoferrin Skin Acne Randomized Trial?

The current Migaku evidence database contains 2 reusable source documents for Lactoferrin Skin Acne Randomized Trial. This answer focuses on benefits, uncertainty, and practical interpretation. - They secrete cytokines and chemokines, promoting the recruitment of macrophages and polymorphs to the skin injury site, and express Toll-like receptors (TLRs), recognizing pathogen-associated molecular patterns (PAMPs). [Guryanova Svetlana V. (2026); evidence level 3] - Dermcidin helps to limit bacterial colonization on the skin during the initial hours after sweating, and therefore effectively reduces the risk of infection by pathogens encountered in the environment. [Guryanova Svetlana V. (2026); evidence level 3] - Patients with atopic dermatitis (AD), for instance, have significantly reduced levels of dermcidin peptides in their sweat []. [Guryanova Svetlana V. (2026); evidence level 3] - 1 2 3 The skin provides the first line of body defense system, employing both physical and chemical barriers to repel pathogens. [Guryanova Svetlana V. (2026); evidence level 3] - These peptides have been associated with immune regulation, anti-inflammatory, and antimicrobial properties [,], possibly modulating the gut microbiome [] and exhibiting systemic activity to mitigate microbial infections []. [Kaplan Nicole (2026); evidence level 4] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.